Axela Acquires Xceed Molecular | GenomeWeb

NEW YORK (GenomeWeb News) – Axela today announced that it has acquired Xceed Molecular for an undisclosed sum.

The deal combined Axela's multiplex protein biomarker testing capabilities with Xceed's Ziplex System for gene expression analysis. Axela said that the new firm, which will operate under its name, will offer clinical researchers a portfolio of products for analysis of proteins, pathogens, DNA, and RNA to speed the validation and clinical application of biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.